U.S. investment in sensitive, cutting-edge research abroad would be more tightly controlled under the proposed National Critical Capabilities Defense Act. The bipartisan legislation would […]
Bill would limit U.S. investment in foreign research Read More »
It feels like just yesterday that Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), visited member company Novavax with Maryland
We partnered with the Biotechnology Innovation Organization (BIO) in 2019 to develop comprehensive news content about the industry and a quick-read daily newsletter with
Welcome to Bio.News Read More »
“Another pandemic is upon us, and policymakers are once again proving slow to respond, to the detriment of global health,” writes Henry B. Skinner,
AMR: ‘We’re already ignoring the next pandemic’ Read More »
The World Trade Organization (WTO) agreed to “a waiver of certain requirements concerning compulsory licensing for COVID-19 vaccines.” However, the waiver of COVID vaccine
WTO agrees to COVID vaccine IP waiver – here’s what we know Read More »
On Day 4 – the final episode of Good Day BIO Live – we have interviews with BIO leadership and policy experts on Accelerated
Good Day BIO LIVE! from San Diego – watch Thursday’s episode Read More »
Accelerated Approval, growing misinformation and declining life expectancy, and the need for more resources on the food side of the agency were among the
FDA Commissioner on Accelerated Approval, misinformation, and food Read More »
On Day 3, the Good Day BIO Team brings you exclusive interviews with BIO’s Phyllis Arthur, Novavax’s John Trizzino, and BioGENEius winner Okezue Bell,
Good Day BIO LIVE! from San Diego – watch Wednesday’s episode Read More »
The market is volatile, to say the least – but it’s not entirely bad for biotechs, especially those with innovative science, said McKinsey &
VC still interested in biotech, says McKinsey Read More »
About 50% of the world’s population are women – and women account for around 85% of spending decisions, said Cathy Friedman, Executive Venture Partner
Women’s health ‘woefully underfunded’ – but that’s changing Read More »
